The global FISH Probe market is expected to grow at growth rate of 8.3% to reach USD 1.58 billion by 2025.

FISH techniques are characterized by its ability to interpret required information at genome level. This technique is been utilized over the past many decade for the identification of various chronic diseases and in signifying accurate and proper treatment options to the physicians.  Increasing number of cancer patients is likely to boost the market growth. As per the statistics released by the National Cancer Institute, in 2016, it was estimated that 1,685,210 new cases of cancer will be diagnosed and 595,650 cancer deaths are anticipated to occur.

Additionally, technological advancements supported the market demand. For instance, Silver ISH (SISH) assay technology, a type of CISH, is one of the emerging technologies in the market. Ventana Medical System introduced the “INFORM HER2 SISH DNA Probe Assay” to detect HER2 gene in breast cancer patients, exclusively in the U.S. SISH is a fully automated method of prenatal cancer diagnostics that saves time by offering faster and consistent results during clinical trials. Other factors such as rise in research activities, favorable government initiatives and others supported the market growth.

The global FISH probe market is segmented in terms of RNA types, end use, application, and technology. In terms of end use the market is divided into clinical, research and companion diagnostics. mRNA AND miRNA are the types of RNA segment. Whereas, application segment is categorized into cancer and genetic diseases diagnostics. Cancer segment has been developing at a double digit growth rate over the forecast period. Most widely known FISH cancer probe tests are the HER2 test for the detection of breast cancer and the UroVysion for detection of bladder cancer test (Abbott Laboratories).

Geographically, Asia Pacific region is anticipated to grow with the highest CAGR during the forecast period owing to the constant support from the government for market development. Currently, in June 2017, the Global Health Innovative Technology Fund (GHIT) announced to provide USD 200 Million to the Japanese government for R&D in the healthcare industry.

GHIT will aim to strengthen its collaboration with Japanese health organizations, such as Japan Agency for Medical Research and Development (AMED), Japan’s Pharmaceutical and Medical Devices Agency (PMDA), Japan International Cooperation Agency (JICA), and other major healthcare companies such as Fujifilm to bring innovations in the field of in-vitro diagnostics. Such initiatives is believed to augment the market growth to great extent.

The market is highly competitive in nature and a limited number of players have a high level of dominance over the overall revenue share. The most notable market participants are Abbott Laboratories, Agilent Technologies, Life Science Technologies, accounted for a considerable share of the market owing to their wide range product offerings to the market. Market leaders are involved in extensive research for technologically advanced products and enhancement of distribution channels.

KEY BENEFITS OF THE REPORT:

• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the competitive landscape of this market
• In-depth analysis of the key factors are propelling the growth of the global market
• Detailed analysis of the geographic region that will witness the strongest growth
• Granular analysis of the current market scenario and the expected market grow

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

MARKET, BY END USE

• Clinical
• Research
• Companion Diagnostics

MARKET, BY RNA TYPE

• Mrna
• miRNA

MARKET, BY RNA TYPE

• Cancer Diagnostics
• Genetic Diseases

MARKET, BY REGION

• North America
• Europe
• Asia Pacific
• Rest of the World

MARKET, BY COUNTRY

• Further Breakdown of The North America Market
  • U.S.
  • Canada
• Further Breakdown of The Europe Market
  • Germany
  • France
  • Rest of Europe
• Further Breakdown of The APAC Market
  • India
  • China
  • Rest of APAC
• Further Breakdown of The Rest of the World Market
  • Middle East and Africa
  • Latin America